United States Advanced Therapy Medicinal Products Market Size, Share, Growth, and Industry Analysis, Type (Cell Therapy, Gene Therapy, Tissue Engineered Products), Application (Oncology, Rare Diseases, Cardiovascular Diseases), Regional Insights and Forecast to 2034

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: United States Advanced Therapy Medicinal Products Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on United States Advanced Therapy Medicinal Products Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. United States Advanced Therapy Medicinal Products Market, Type
   1. Introduction
      1. Market Size and Forecast, Type
   2. Cell Therapy
      1. Market Size and Forecast, By Region
   3. Gene Therapy
      1. Market Size and Forecast, By Region
   4. Tissue Engineered Products
      1. Market Size and Forecast, By Region
10. United States Advanced Therapy Medicinal Products Market, Application
    1. Introduction
       1. Market Size and Forecast, Application
    2. Oncology
       1. Market Size and Forecast, By Region
    3. Rare Diseases
       1. Market Size and Forecast, By Region
    4. Cardiovascular Diseases
       1. Market Size and Forecast, By Region
11. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. U.S.
       1. Market Size and Forecast
          1. Type
             1. Cell Therapy
             2. Gene Therapy
             3. Tissue Engineered Products
          2. Application
             1. Oncology
             2. Rare Diseases
             3. Cardiovascular Diseases
12. Competitive Landscape, 2025
    1. Introduction
    2. United States Advanced Therapy Medicinal Products Market Share Analysis, 2025 (%)
       1. Market Share Analysis, 2025
       2. Competition Ranking, 2025
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
13. Company Profile
    1. Novartis AG
       1. Business Overview
       2. Financial Data
       3. Key Product domains
       4. Recent Developments
    2. Gilead Sciences Inc.
    3. Bluebird Bio Inc.
    4. Amgen Inc.
    5. Bristol-Myers Squibb
    6. Pfizer Inc.
    7. Roche Holding AG
    8. Biogen Inc.
    9. Takeda Pharmaceutical Company
    10. Regeneron Pharmaceuticals
    11. Sanofi SA
    12. AstraZeneca plc